Skip to main content

Advertisement

Log in

Coffee consumption and the risk of cancer in the Norwegian Women and Cancer (NOWAC) Study

  • CANCER
  • Published:
European Journal of Epidemiology Aims and scope Submit manuscript

Abstract

An association between coffee consumption and cancer has long been investigated. Coffee consumption among Norwegian women is high, thus this is a favorable population in which to study the impact of coffee on cancer incidence. Information on coffee consumption was collected from 91,767 women at baseline in the Norwegian Women and Cancer Study. These information were applied until follow-up information on coffee consumption, collected 6–8 years after baseline, became available. Multiple imputation was performed as a method for dealing with missing data. Multivariable Cox regression models were used to calculate hazard ratios (HR) for breast, colorectal, lung, and ovarian cancer, as well as cancer at any site. We observed a 17 % reduced risk of colorectal cancer (HR = 0.83, 95 % CI 0.70–0.98, p trend across categories of consumption = 0.10) and a 9 % reduced risk of cancer at any site (HR = 0.91, 95 % CI 0.86–0.97, p trend = 0.03) in women who drank more than 3 and up to 7 cups/day, compared to women who drank ≤1 cup/day. A significantly increased risk of lung cancer was observed with a heavy coffee consumption (>7 vs. ≤1 cup/day HR = 2.01, 95 % CI 1.47–2.75, p trend < 0.001). This was most likely caused by residual confounding due to smoking, as no statistically significant association was observed in never smokers (>5 vs. ≤1 cup/day HR = 1.42, 95 % CI 0.44–4.57, p trend = 0.30). No significant association was found between coffee consumption and the risk of breast or ovarian cancer. In this study, coffee consumption was associated with a modest reduced risk of cancer at any site. Residual confounding due to smoking may have contributed to the positive association between high coffee consumption and the risk of lung cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. International Coffee Council. Trends in coffee consumption in selected importing countries. 2015.

  2. Li G, Ma D, Zhang Y, Zheng W, Wang P. Coffee consumption and risk of colorectal cancer: a meta-analysis of observational studies. Public Health Nutr. 2013;16(2):346–57.

    Article  CAS  PubMed  Google Scholar 

  3. Jiang W, Wu Y, Jiang X. Coffee and caffeine intake and breast cancer risk: an updated dose-response meta-analysis of 37 published studies. Gynecol Oncol. 2013;129(3):620–9.

    Article  CAS  PubMed  Google Scholar 

  4. Tang N, Wu Y, Ma J, Wang B, Yu R. Coffee consumption and risk of lung cancer: a meta-analysis. Lung Cancer. 2010;67(1):17–22.

    Article  PubMed  Google Scholar 

  5. Braem MG, Onland-Moret NC, Schouten LJ, Tjonneland A, Hansen L, Dahm CC, et al. Coffee and tea consumption and the risk of ovarian cancer: a prospective cohort study and updated meta-analysis. Am J Clin Nutr. 2012;95(5):1172–81.

    Article  CAS  PubMed  Google Scholar 

  6. Yu X, Bao Z, Zou J, Dong J. Coffee consumption and risk of cancers: a meta-analysis of cohort studies. BMC Cancer. 2011;11:96.

    Article  PubMed  PubMed Central  Google Scholar 

  7. Stensvold I, Jacobsen BK. Coffee and cancer: a prospective study of 43,000 Norwegian men and women. Cancer Causes Control. 1994;5(5):401–8.

    Article  CAS  PubMed  Google Scholar 

  8. Cancer Registry of Norway IoPCR. Cancer in Norway 2013. 2015.

  9. World Cancer Research Fund, American Institute for Cancer Research. Food, Nutrition, Physical Activity, and the Prevention of Cancer: a Global Perspective. 2007.

  10. Gavrilyuk O, Braaten T, Skeie G, Weiderpass E, Dumeaux V, Lund E. High coffee consumption and different brewing methods in relation to postmenopausal endometrial cancer risk in the Norwegian women and cancer study: a population-based prospective study. BMC Womens Health. 2014;14:48.

    Article  PubMed  PubMed Central  Google Scholar 

  11. Lund E, Dumeaux V, Braaten T, Hjartaker A, Engeset D, Skeie G, et al. Cohort profile: the Norwegian Women and Cancer Study–NOWAC–Kvinner og kreft. Int J Epidemiol. 2008;37(1):36–41.

    Article  PubMed  Google Scholar 

  12. Hjartaker A, Andersen LF, Lund E. Comparison of diet measures from a food-frequency questionnaire with measures from repeated 24-hour dietary recalls. The Norwegian Women and Cancer Study. Public Health Nutr. 2007;10(10):1094–103.

    Article  PubMed  Google Scholar 

  13. Hu FB, Stampfer MJ, Rimm E, Ascherio A, Rosner BA, Spiegelman D, et al. Dietary fat and coronary heart disease: a comparison of approaches for adjusting for total energy intake and modeling repeated dietary measurements. Am J Epidemiol. 1999;149(6):531–40.

    Article  CAS  PubMed  Google Scholar 

  14. Beral V. Breast cancer and hormone-replacement therapy in the Million Women Study. Lancet. 2003;362(9382):419–27.

    Article  CAS  PubMed  Google Scholar 

  15. Benowitz NL, Peng M, Jacob P III. Effects of cigarette smoking and carbon monoxide on chlorzoxazone and caffeine metabolism. Clin Pharmacol Ther. 2003;74(5):468–74.

    Article  CAS  PubMed  Google Scholar 

  16. Bakuradze T, Boehm N, Janzowski C, Lang R, Hofmann T, Stockis JP, et al. Antioxidant-rich coffee reduces DNA damage, elevates glutathione status and contributes to weight control: results from an intervention study. Mol Nutr Food Res. 2011;55(5):793–7.

    Article  CAS  PubMed  Google Scholar 

  17. Collomp K, Anselme F, Audran M, Gay JP, Chanal JL, Prefaut C. Effects of moderate exercise on the pharmacokinetics of caffeine. Eur J Clin Pharmacol. 1991;40(3):279–82.

    Article  CAS  PubMed  Google Scholar 

  18. Sterne JA, White IR, Carlin JB, Spratt M, Royston P, Kenward MG, et al. Multiple imputation for missing data in epidemiological and clinical research: potential and pitfalls. BMJ. 2009;338:b2393.

    Article  PubMed  PubMed Central  Google Scholar 

  19. White IR, Royston P. Imputing missing covariate values for the Cox model. Stat Med. 2009;28(15):1982–98.

    Article  PubMed  PubMed Central  Google Scholar 

  20. Rubin DB. Multiple imputation after 18+ years. J Am Stat Assoc. 1996;91(434):473–89.

    Article  Google Scholar 

  21. Lund E, Kumle M, Braaten T, Hjartaker A, Bakken K, Eggen E, et al. External validity in a population-based national prospective study–the Norwegian Women and Cancer Study (NOWAC). Cancer Causes Control. 2003;14(10):1001–8.

    Article  PubMed  Google Scholar 

  22. Bamia C, Lagiou P, Jenab M, Trichopoulou A, Fedirko V, Aleksandrova K, et al. Coffee, tea and decaffeinated coffee in relation to hepatocellular carcinoma in a European population: multicentre, prospective cohort study. Int J Cancer. 2015;136(8):1899–908.

    Article  CAS  PubMed  Google Scholar 

  23. Aleksandrova K, Bamia C, Drogan D, Lagiou P, Trichopoulou A, Jenab M, et al. The association of coffee intake with liver cancer risk is mediated by biomarkers of inflammation and hepatocellular injury: data from the European Prospective Investigation into Cancer and Nutrition. Am J Clin Nutr. 2015;102(6):1498–508.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Statistics Norway. Smoking habits, 2014.

  25. White IR, Royston P, Wood AM. Multiple imputation using chained equations: issues and guidance for practice. Stat Med. 2011;30(4):377–99.

    Article  PubMed  Google Scholar 

  26. Nilsson LM, Johansson I, Lenner P, Lindahl B, Van GB. Consumption of filtered and boiled coffee and the risk of incident cancer: a prospective cohort study. Cancer Causes Control. 2010;21(10):1533–44.

    Article  PubMed  Google Scholar 

  27. Hirvonen T, Mennen LI, de Bree A, Castetbon K, Galan P, Bertrais S, et al. Consumption of antioxidant-rich beverages and risk for breast cancer in French women. Ann Epidemiol. 2006;16(7):503–8.

    Article  PubMed  Google Scholar 

  28. Bhoo Pathy N, Peeters P, van Gils C, Beulens JW, van der Graaf Y, Bueno-de-Mesquita B, et al. Coffee and tea intake and risk of breast cancer. Breast Cancer Res Treat. 2010;121(2):461–7.

    Article  CAS  PubMed  Google Scholar 

  29. Michels KB, Holmberg L, Bergkvist L, Wolk A. Coffee, tea, and caffeine consumption and breast cancer incidence in a cohort of Swedish women. Ann Epidemiol. 2002;12(1):21–6.

    Article  PubMed  Google Scholar 

  30. Ganmaa D, Willett WC, Li TY, Feskanich D, van Dam RM, Lopez-Garcia E, et al. Coffee, tea, caffeine and risk of breast cancer: a 22-year follow-up. Int J Cancer. 2008;122(9):2071–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Bhoo-Pathy N, Peeters PH, Uiterwaal CS, Bueno-de-Mesquita HB, Bulgiba AM, Bech BH, et al. Coffee and tea consumption and risk of pre- and postmenopausal breast cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort study. Breast Cancer Res. 2015;17:15.

    Article  PubMed  PubMed Central  Google Scholar 

  32. Oh JK, Sandin S, Strom P, Lof M, Adami HO, Weiderpass E. Prospective study of breast cancer in relation to coffee, tea and caffeine in Sweden. Int J Cancer. 2015;137(8):1979–89.

    Article  CAS  PubMed  Google Scholar 

  33. Larsson SC, Bergkvist L, Giovannucci E, Wolk A. Coffee consumption and incidence of colorectal cancer in two prospective cohort studies of Swedish women and men. Am J Epidemiol. 2006;163(7):638–44.

    Article  PubMed  Google Scholar 

  34. Michels KB, Willett WC, Fuchs CS, Giovannucci E. Coffee, tea, and caffeine consumption and incidence of colon and rectal cancer. J Natl Cancer Inst. 2005;97(4):282–92.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  35. Dik VK, Bueno-de-Mesquita HB, Van Oijen MG, Siersema PD, Uiterwaal CS, Van Gils CH, et al. Coffee and tea consumption, genotype-based CYP1A2 and NAT2 activity and colorectal cancer risk-results from the EPIC cohort study. Int J Cancer. 2014;135(2):401–12.

    Article  CAS  PubMed  Google Scholar 

  36. Yamada H, Kawado M, Aoyama N, Hashimoto S, Suzuki K, Wakai K, et al. Coffee consumption and risk of colorectal cancer: the Japan Collaborative Cohort Study. J Epidemiol. 2014;24(5):370–8.

    Article  PubMed  Google Scholar 

  37. Xie Y, Qin J, Nan G, Huang S, Wang Z, Su Y. Coffee consumption and the risk of lung cancer: an updated meta-analysis of epidemiological studies. Eur J Clin Nutr 2015;70(2):199–206.

    Article  PubMed  Google Scholar 

  38. Guertin KA, Freedman ND, Loftfield E, Graubard BI, Caporaso NE, Sinha R. Coffee consumption and incidence of lung cancer in the NIH-AARP Diet and Health Study. Int J Epidemiol 2015. doi:10.1093/ije/dyv104.

    Google Scholar 

  39. Gu L, Gonzalez FJ, Kalow W, Tang BK. Biotransformation of caffeine, paraxanthine, theobromine and theophylline by cDNA-expressed human CYP1A2 and CYP2E1. Pharmacogenetics. 1992;2(2):73–7.

    Article  CAS  PubMed  Google Scholar 

  40. Hukkanen J, Jacob P III, Peng M, Dempsey D, Benowitz NL. Effect of nicotine on cytochrome P450 1A2 activity. Br J Clin Pharmacol. 2011;72(5):836–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  41. Shearer J, Farah A, de Paulis T, Bracy DP, Pencek RR, Graham TE, et al. Quinides of roasted coffee enhance insulin action in conscious rats. J Nutr. 2003;133(11):3529–32.

    CAS  PubMed  Google Scholar 

  42. Renehan AG, Roberts DL, Dive C. Obesity and cancer: pathophysiological and biological mechanisms. Arch Physiol Biochem. 2008;114(1):71–83.

    Article  CAS  PubMed  Google Scholar 

  43. Oh JH, Lee JT, Yang ES, Chang JS, Lee DS, Kim SH, et al. The coffee diterpene kahweol induces apoptosis in human leukemia U937 cells through down-regulation of Akt phosphorylation and activation of JNK. Apoptosis. 2009;14(11):1378–86.

    Article  CAS  PubMed  Google Scholar 

  44. Majer BJ, Hofer E, Cavin C, Lhoste E, Uhl M, Glatt HR, et al. Coffee diterpenes prevent the genotoxic effects of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) and N-nitrosodimethylamine in a human derived liver cell line (HepG2). Food Chem Toxicol. 2005;43(3):433–41.

    Article  CAS  PubMed  Google Scholar 

  45. Higgins LG, Cavin C, Itoh K, Yamamoto M, Hayes JD. Induction of cancer chemopreventive enzymes by coffee is mediated by transcription factor Nrf2. Evidence that the coffee-specific diterpenes cafestol and kahweol confer protection against acrolein. Toxicol Appl Pharmacol. 2008;226(3):328–37.

    Article  CAS  PubMed  Google Scholar 

  46. Kotsopoulos J, Eliassen AH, Missmer SA, Hankinson SE, Tworoger SS. Relationship between caffeine intake and plasma sex hormone concentrations in premenopausal and postmenopausal women. Cancer. 2009;115(12):2765–74.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  47. Deplanque G, Vincent F, Mah-Becherel MC, Cazenave JP, Bergerat JP, Klein-Soyer C. Caffeine does not cause override of the G2/M block induced by UVc or gamma radiation in normal human skin fibroblasts. Br J Cancer. 2000;83(3):346–53.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  48. Deplanque G, Ceraline J, Mah-Becherel MC, Cazenave JP, Bergerat JP, Klein-Soyer C. Caffeine and the G2/M block override: a concept resulting from a misleading cell kinetic delay, independent of functional p53. Int J Cancer. 2001;94(3):363–9.

    Article  CAS  PubMed  Google Scholar 

  49. Muller WU, Bauch T, Wojcik A, Bocker W, Streffer C. Comet assay studies indicate that caffeine-mediated increase in radiation risk of embryos is due to inhibition of DNA repair. Mutagenesis. 1996;11(1):57–60.

    Article  CAS  PubMed  Google Scholar 

Download references

Author contributions

ML carried out the statistical analysis and drafted the manuscript. IL contributed with the interpretation of the data and revision of the manuscript. EL was responsible for critical revision of the manuscript. EL is also the PI of the NOWAC. GS and EW critically revised the manuscript. TB developed the research plan, prepared the data, revised the manuscript, and provided critical help for the multiple imputation modeling.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Marko Lukic.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (DOCX 23 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lukic, M., Licaj, I., Lund, E. et al. Coffee consumption and the risk of cancer in the Norwegian Women and Cancer (NOWAC) Study. Eur J Epidemiol 31, 905–916 (2016). https://doi.org/10.1007/s10654-016-0142-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10654-016-0142-x

Keywords

Navigation